A microporous membrane oxygenator (TMO) has been used in 44 clinical perfusions for cardiac surgery. This oxygenator's primary advantage has been the ability to control oxygenation and carbon dioxide separately prevented hypocarbia. The oxygenator has been shown to have fewer deleterious effects on the formed elements of the blood and good O2 and CO2 transfer.
